while the FII test gave the most positive results in the rheumatoid arthritis population, but 11 % of normals were also positive.
The observation that sera from rheumatoid arthritic patients were able to aggregate sensitised sheep cells was made independently by Waaler while the FII test gave the most positive results in the rheumatoid arthritis population, but 11 % of normals were also positive.
A new approach to the measurement of rheumatoid factors is nephelometry, a technique that has many laboratory applications in the routine measurement of proteins.4 5 The principle of this process is based on the fact that an antibody-antigen complex in a beam of light will scatter the light in proportion to the concentration of the complex present. The procedure therefore is to establish a baseline for each individual sample by placing the sample in the beam of light and then adding a known amount of specific antibody for the protein in question, allowing it to incubate for 20 minutes. The sample is then placed in the beam of light again, and the difference in light scattering before and after adding the antibody is recorded on the machine in arbitrary units and is proportional to the amount of antibodyantigen complex present. For this study the IgM rheumatoid factor in the patient's serum is reacted with human heat-aggregated IgG as supplied by the manufacturers (LAS-R rheumatoid factor antigen (human)).
We describe a comparative study on 92 patients from the rheumatology clinic at the University Hospital of Wales whose sera were measured for rheumatoid factor by the routine latex screening test plus DAT and, secondly, by nephelometry. The laser nephelometer was kindly loaned by Travenol Laboratories-Model No. PDQ (semi-automated).
Material and methods Results
A total of 92 patients attending the rheumatology clinic with a variety of arthritic complaints were selected at random, and venous blood was aspirated in a routine manner into a plastic syringe; 10 ml was then sent to the laboratory in a plastic tube for latex and DAT tests while a further 10 ml was retained in the rheumatology department. This was allowed to clot for 1 hour at room temperature and was then centrifuged. The serum was taken off, decanted into a fresh container, relabelled, and frozen at -20°C. When approximately 35 samples had been collected in this way they were transported without defrosting to the haematology laboratory where they were subsequently tested on the nephelometer. The samples, after being renumbered, were tested under blind conditions, and after each batch had been measured the results were plotted on a graph of DAT titre v nephelometry score. In order to test the variability of the nephelometry method, blood was taken from 21 inpatients with rheumatoid arthritis. Each sample was divided into two, and the batch of specimens was sent to the laboratory as described above after randomising and renumbering. The duplicate specimens were tested in a single batch. The results of the study are shown in the Figure, which plots the DAT measured in dilutions on the horizontal axis and the nephelometer results measured in arbitrary units on the vertical axis. A correlation coefficient between the two has not been calculated because the DAT titre, being measured by double dilutions, is non-linear. The object of the graph, therefore, is to ascertain whether seropositive patients (DAT > 1:32) also had a high nephelometry score and seronegative patients a low score. Seropositive and seronegative results were differentiated on the graph by a vertical line, but as there is no figure in current use dividing significant nephelometry scores from non-significant ones this has been calculated in the first instance to give the best agreement with the DAT results. Routine rheumatoid factor measurements have been in use now for 30 years and they ought perhaps to be able to provide more information than simply a screening test for rheumatoid disease. This can in any case be carried out as a latex slide test (Hyland, Rheumaton), a result being obtained in less than 2 minutes. The sensitivity of the Rheumaton test is very close to that of the conventional DAT,7 and common laboratory practice is to use this as a screening test and the more laborious DAT only on those patients who gave a positive result. The slide test, however, gives only a positive or negative result, and no more information is available from it.
Attempts have been made to correlate the DAT titre with prognosis or severity of the rheumatoid disease, but Lloyd et al.7 could not detect any significant correlation with any other parameters in rheumatoid patients. Although the unreliability of the test must be a major factor in this, the cut-off point of 1/32, below which the test is not considered to be significantly positive, results in a number of patients with rheumatoid arthritis by all other criteria being considered seronegative. This often gives the unwary clinician a false sense of security, whereas in practice such patients are frequently as liable to erosive disease as those who are strongly seropositive.
The figure of 1/32 has been reached on epidemiological grounds,8 9 and the result in practical terms is that there is a significant overlap between the rheumatoid population and the normal population in the low DAT titre range. It is not yet clear whether there is a similar overlap in the nephelometry scores, but the results shown in the Figure show that the nephelometry significance point could be reduced from 20 to 10 units and still discriminate accurately between the rheumatoid and the non-rheumatoid population. Further studies are in progress to establish exactly where this cut-off point should be.
